Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00164619 · ClinicalTrials.gov registry record · Phase 2

Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR

A Phase 2 study, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
Phase 2
Development phase
3,660
Enrollment target

NCT00164619 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 3,660 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00164619, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
Phase 2
Development phase
3,660 participants
Enrollment target

Study Summary

The purpose of the project is to determine whether the VOICES/VOCES intervention, that was shown to be effective in a research study, is still effective when delivered by STD/HIV prevention agencies. VOICES/VOCES is a brief, single-session intervention for African-American and Latino adult men and women at high risk for STD/HIV. It encourages condom use and improves condom negotiation skills. A health educator delivers the intervention to groups of 4 to 8 clinic patients in a private room. Groups are made up of people of the same sex and same race or ethnicity. Information on STD/HIV risk behaviors and condom use is delivered by culturally-specific videos, group discussion, and a poster presenting features of various condom brands. Participants role-play condom negotiation modeled in the videos. At the end of the session they are given sample condoms of their choice. In this project, health educators from the health departments of New York City and San Juan, Puerto Rico conducted the VOICES/VOCES intervention with a sample of patients from one STD clinic in each of their cities. Researchers helped the health departments test whether the intervention is effective when local health educators deliver it.

Interventions

  • BEHAVIORAL VOICES/VOCES
  • BIOLOGICAL Standard STD clinic services

Trial Details

FieldValue
Enrollment Target 3,660 participants
Start Date 2001-07
Est. Completion 2008-03
Phase Phase 2

What the Registry Record Tells You About NCT00164619

The ClinicalTrials.gov registry entry for NCT00164619 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3,660 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which VOICES/VOCES is the first listed.

NCT00164619 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00164619 about?

NCT00164619 is a clinical study titled "Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR". The purpose of the project is to determine whether the VOICES/VOCES intervention, that was shown to be effective in a research study, is still effective when delivered by STD/HIV prevention agencies. VOICES/VOCES is a brief, single-session intervention for African-American and Latino adult men and ...

What is the current status of trial NCT00164619?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 3,660 participants. The study started on 2001-07. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00164619?

The interventions under investigation include: VOICES/VOCES (BEHAVIORAL), Standard STD clinic services (BIOLOGICAL).

Who is sponsoring clinical trial NCT00164619?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.